Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
VolitionRx Limited Announces Strategic Acquisition
2019-12-16 21:30
VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test
2019-12-05 21:30
VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia
2019-12-03 21:30
VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update
2019-11-07 21:30
Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video
2019-10-29 20:30
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
2019-10-26 00:00
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas
2019-10-18 20:30
Volition Appoints Dr. Phillip Barnes to Board of Directors
2019-10-10 04:05
Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes
2019-09-17 20:35
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer
2019-08-08 20:30
VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update
2019-08-07 20:45
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
2019-07-25 04:05
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
2019-07-18 20:30
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
2019-07-10 20:30
VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update
2019-05-07 04:05
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics
2019-04-09 20:30
VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China
2019-03-28 22:48
VolitionRx Limited to Present at Conferences in March & April 2019
2019-03-25 20:40
VolitionRx Limited to Present at Conferences in the U.S. Next Week
2019-03-15 20:30
VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update
2019-03-14 04:05
1
2
3
4
5
6
11